These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology. Shilova O; Shramova E; Proshkina G; Deyev S Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067057 [TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
12. Engineered Polymer-Transferrin Conjugates as Self-Assembling Targeted Drug Delivery Systems. Makwana H; Mastrotto F; Magnusson JP; Sleep D; Hay J; Nicholls KJ; Allen S; Alexander C Biomacromolecules; 2017 May; 18(5):1532-1543. PubMed ID: 28350442 [TBL] [Abstract][Full Text] [Related]
13. Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: differential cytotoxicity. Middlebrook JL; Dorland RB Can J Microbiol; 1977 Feb; 23(2):183-9. PubMed ID: 65205 [TBL] [Abstract][Full Text] [Related]
14. Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy. Um W; Park J; Ko H; Lim S; Yoon HY; Shim MK; Lee S; Ko YJ; Kim MJ; Park JH; Lim DK; Byun Y; Kwon IC; Kim K Biomaterials; 2019 Dec; 224():119494. PubMed ID: 31542518 [TBL] [Abstract][Full Text] [Related]
15. Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrol. Abdelmoneem MA; Abd Elwakil MM; Khattab SN; Helmy MW; Bekhit AA; Abdulkader MA; Zaky A; Teleb M; Elkhodairy KA; Albericio F; Elzoghby AO Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111422. PubMed ID: 33255023 [TBL] [Abstract][Full Text] [Related]
16. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558 [TBL] [Abstract][Full Text] [Related]
18. RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer. Li F; Zhao Y; Mao C; Kong Y; Ming X Mol Pharm; 2017 Aug; 14(8):2793-2804. PubMed ID: 28700237 [TBL] [Abstract][Full Text] [Related]
19. Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines. Álamo P; Cedano J; Conchillo-Sole O; Cano-Garrido O; Alba-Castellon L; Serna N; Aviñó A; Carrasco-Diaz LM; Sánchez-Chardi A; Martinez-Torró C; Gallardo A; Cano M; Eritja R; Villaverde A; Mangues R; Vazquez E; Unzueta U Acta Biomater; 2021 Aug; 130():211-222. PubMed ID: 34116228 [TBL] [Abstract][Full Text] [Related]
20. Cyclic RGD-Peptide-Functionalized Polylipopeptide Micelles for Enhanced Loading and Targeted Delivery of Monomethyl Auristatin E. Qiu M; Wang X; Sun H; Zhang J; Deng C; Zhong Z Mol Pharm; 2018 Nov; 15(11):4854-4861. PubMed ID: 30259747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]